Obese people ‘will have to wait’ for Mounjaro amid carefully managed NHS rollout - The decision will help ‘protect other ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Following its endorsement of Eli Lilly’s obesity medicine tirzepatide, England’s National Institute for Health and Care ...

However the NHS spending watchdog has announced Mounjaro will only be given to 220,000 people in England during the first three years - despite 3.4 million people being eligible for it. Trials have ...

Mounjaro is a treatment for Type 2 diabetes that activates GIP and GLP-1 pathways to help regulate blood sugar. It’s part of ...

Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...

Jim Gaffigan revealed he lost 50 pounds via a weight loss drug after struggling for years with his weight. Photos show the ...

Eli Lilly said its drug Zepbound led to greater weight reduction than rival Novo Nordisk's Wegovy in a head-to-head ...

A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...

The paper says France is in "turmoil" and the crisis will "reverberate across Europe", noting that former Brexit negotiator ...

As the Biden administration is proposing drugs like Ozempic and Wegovy be covered by Medicare and Medicaid, Black people need ...

The guidelines are part of a national trend by municipal governments and private firms struggling to manage ballooning costs ...